Clinical Trial Update: Evaluation of the Use of Indomethacin as Co-treatment in Women With Preterm Labor and High Risk of Intraamniotic Inflammation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating indomethacin as a co-treatment in women with preterm labor at high risk of intraamniotic inflammation has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraamniotic Inflammation
• Preterm Labor

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: Sara Varea | Conditions: Preterm Labor With Intact Membranes | Phase 2 | Status: COMPLETED